Company profile for Codagenix

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Codagenix is a clinical stage synthetic biology company that uses software to recode the genomes of viruses, constructing live-attenuated vaccines or viruses to prevent viral infections or treat solid tumors. Codagenix’s recoded vaccine candidates are a perfect antigenic match to the target virus and induce a robust immune response to all viral antigens. For cancer, our nimble platform allows us to turn a virus into a potent...
Codagenix is a clinical stage synthetic biology company that uses software to recode the genomes of viruses, constructing live-attenuated vaccines or viruses to prevent viral infections or treat solid tumors. Codagenix’s recoded vaccine candidates are a perfect antigenic match to the target virus and induce a robust immune response to all viral antigens. For cancer, our nimble platform allows us to turn a virus into a potential oncolytic immuno-oncology therapies. Both programs rely on scalable, low-cost manufacturing.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
3 Bioscience Park Drive Farmingdale NY 11735
Telephone
Telephone
youtube
YouTube

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

DDL Conference

Not Confirmed

envelop Contact Supplier

DDL Conference

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.prnewswire.com/news-releases/codagenix-awarded-path-subcontract-to-develop-stabilized-novel-oral-polio-vaccine-candidates-302508784.html

PR NEWSWIRE
22 Jul 2025

https://www.prnewswire.com/news-releases/codagenix-receives-additional-award-from-us-department-of-defense-to-advance-development-of-dengue-vaccine-301962970.html

PR NEWSWIRE
24 Oct 2023

https://www.prnewswire.com/news-releases/codagenix-announces-late-breaking-presentation-of-positive-clinical-immunogenicity-data-for-covid-19-vaccine-candidate-coviliv-at-idweek-2023-301952953.html

PR NEWSWIRE
11 Oct 2023

https://www.clinicaltrialsarena.com/news/codagenix-vaccine-rsv-trial/

CLINICAL TRIALS ARENA
11 May 2023

https://www.prnewswire.com/news-releases/codagenix-initiates-dosing-in-phase-1-study-of-intranasal-live-attenuated-rsv-vaccine-codavax--rsv-in-a-pediatric-population-301819768.html

PR NEWSWIRE
10 May 2023

https://www.prnewswire.com/news-releases/codagenix-announces-appointment-of-kimber-poffenberger-phd-as-chief-strategy-officer-301781472.html

PR NEWSWIRE
28 Mar 2023

REF. STANDARDS & IMPURITIES

Upload your portfolio for free, ask us

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty